Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals is a biotechnology company specializing in the development of RNA-targeted therapeutics. Founded in 1989, they are pioneers in the field, leading the way in discovering and developing innovative medicines for a wide range of diseases. Their technology platform, known as antisense technology, allows them to target specific genes and modify their expression, offering hope for patients with limited or no treatment options.

Ionis boasts a strong track record with five marketed medicines and a robust pipeline of over 40 first-in-class or best-in-class candidates. Their portfolio targets areas of high unmet medical need, including neurology, cardiology, and metabolic disorders. The company is committed to operating responsibly and sustainably, with a strong focus on diversity, equity, and inclusion within their workforce and a dedication to supporting patient communities.

Ionis Pharmaceuticals offers a flexible work environment with benefits like 3 weeks of vacation, 19 paid holidays, 2 weeks of sick time, and 2 days of volunteer time off for US employees. Additionally, flexible spending accounts are available for health and dependent day care needs. These options provide employees with the ability to manage their work-life balance effectively.

Ionis Pharmaceuticals offers a highly competitive benefits package, varying slightly based on location. In the US, benefits include comprehensive medical, dental, and vision plans, a 401k plan with a 100% company match on the first 5% of employee contributions, stock options, RSUs, and an Employee Stock Purchase Plan. Additionally, employees receive 3 weeks of vacation, 19 paid holidays, 2 weeks of sick time, 2 days of volunteer time off, and flexible spending accounts. Outside of the US, benefits include company-paid healthcare, pension/retirement contributions, stock options/RSUs, and annual leave.

Ionis Pharmaceuticals is dedicated to the discovery, development and delivery of life-transforming genetic medicines that target the root causes of disease. They are driven by the goal of providing hope for patients with serious diseases and strive to create a healthier and more resilient future for all. Their focus on innovation and determination is rooted in their commitment to partnering with patients to understand their needs and improve their lives.

Ionis Pharmaceuticals promotes a culture that values innovation, collaboration, and a deep commitment to patients. They foster a respectful and inclusive environment where employees feel empowered to contribute, challenge ideas, and grow both personally and professionally. The company emphasizes a strong work ethic, a sense of humor, and a commitment to delivering on the promise of life-transforming medicines.

Ionis Pharmaceuticals is committed to diversity, equity and inclusion (DEI) in its workforce, believing that prejudicial barriers to human potential and productivity are unacceptable. They have a formal DEI strategy focused on four key elements: Engage, Empower, Evaluate, and Evolve. This includes fostering inclusion through employee resource groups, facilitating learning through DEI training, and publicly reporting on their progress in achieving diversity across their organization. Ionis aims to create an inclusive environment where all employees feel empowered to contribute their unique perspectives, leading to improved idea generation and innovation.